等待開盤 03-26 09:30:00 美东时间
+1.410
+4.01%
今日重点评级关注:HC Wainwright & Co.:维持Perspective Therapeutics"买入"评级,目标价从12美元升至13美元;Litchfield Hills:维持Star Equity Holdings"买入"评级,目标价从21美元升至28美元
03-24 10:07
Wells Fargo analyst Benjamin Burnett maintains Liquidia (NASDAQ:LQDA) with a Overweight and raises the price target from $44 to $51.
03-23 21:20
今日重点评级关注:Freedom Capital Markets:维持LifeMD"买入"评级,目标价从8美元升至10美元;Chardan Capital:维持Opus Genetics"买入"评级,目标价从9美元升至11美元
03-13 09:59
United Therapeutics Corporation (UTHR) announced a stock repurchase program authorized by its board of directors, allowing for up to $2 billion in buybacks over the next year. The company has also sig...
03-09 19:37
今日重点评级关注:HC Wainwright & Co.:维持BridgeBio Oncology"买入"评级,目标价从27美元升至29美元;韦德布什:维持WAVE Life Sciences"跑赢大市"评级,目标价从33美元升至35美元
03-09 11:47
Liquidia Corp (LQDA) reported mixed Q4 results, with earnings missing estimates but sales beating expectations. Analysts have mixed opinions on stock.
03-07 00:17
Across the recent three months, 7 analysts have shared their insights on Liquid...
03-06 21:00
HC Wainwright & Co. analyst Andrew S. Fein maintains Liquidia (NASDAQ:LQDA) with a Buy and raises the price target from $50 to $55.
03-06 20:25
华盛资讯3月5日讯,Liquidia Technologies公布2025财年年度业绩,公司年度营收1.58亿美元,同比增长1031.2%,归母净利润亏损0.69亿美元,同比亏损缩窄46.3%。
03-05 20:17
华盛资讯3月5日讯,Liquidia Technologies公布2025财年Q4业绩,公司Q4营收0.92亿美元,同比增长3054.6%,归母净利润0.15亿美元,扭亏为盈。
03-05 20:07